Detailed explanation of common side effects and relief methods of Mobotinib

Mobocertinib, also known as mobocertinib, is an oral EGFR tyrosine kinase inhibitor (TKI), mainly used for For the treatment of patients with non-small cell lung cancer (NSCLC) carrying EGFR exon 20 insertion mutations. As a targeted drug targeting this rare genetic mutation, mobotinib is of great significance in improving patient survival prognosis. However, while the drug is effective, it may also cause a series of adverse reactions. Understanding its common side effects and coping strategies is particularly critical to optimizing treatment effects and improving patients' quality of life.

1. Common types of side effects

1.Gastrointestinal reactions

One of the most common adverse reactions of mobotinib is gastrointestinal symptoms, especially diarrhea. According to clinical research data, more than 90% of patients experienced varying degrees of diarrhea during the use of this drug, of which approximately 20%-25% were grade 3 or above. In addition, there are patients with symptoms such as nausea, vomiting, loss of appetite, and abdominal pain.

2.Skin-related adverse reactions

Rash is another common side effect. Some patients may also experience dry skin, itching, nail changes (such as nail inflammation and brittleness), hand-foot syndrome, etc. These symptoms usually appear early in the medication and are related to dose and body constitution.

3.Abnormal liver function

Mobotinib can cause an increase in liver enzymes (such asALT, AST), and some patients may develop jaundice or other abnormalities in liver function. Therefore, during medication, liver function indicators need to be checked regularly to detect potential risks in a timely manner.

4.ECGQTInterval prolongation

Although less common, mobotinib may also prolong the QT interval and increase the risk of arrhythmia. Such side effects need to be identified early through electrocardiogram (ECG) monitoring, especially in patients with underlying cardiac diseases.

5.Other symptoms

Fatigue, weakness, dyspnea, cough, etc. are also common systemic reactions. Some patients may also experience weight loss or electrolyte disorders, such as hypokalemia, hypomagnesemia, etc.

2. Side effects mitigation and management methods

1. Strategies for dealing with diarrhea

For mild to moderate diarrhea, doctors usually recommend that patients use an over-the-counter anti-diarrhoeal medicine, such as loperamide (loperamide ). Doctors may prescribe these medications before starting treatment and instruct patients to take them as soon as symptoms occur. At the same time, attention should be paid to dietary adjustments, avoiding greasy, spicy and high-fiber foods, and supplementing with sufficient water and electrolytes to prevent dehydration. In the case of severe diarrhea or diarrhea that lasts for more than 48 hours, you should contact your doctor in time. If necessary, you can suspend the medication or reduce the dosage.

2.Skin management

Skin side effects can generally be relieved by moisturizing, avoiding the sun, using antibiotic ointments (such as erythromycin or clindamycin), and taking oral antibiotics. For more severe rashes, your doctor may recommend a short course of low-dose oral corticosteroids. Nailitis can be controlled with topical antimicrobial care and dry hygiene.

3.Liver function monitoring and protection

Liver function should be tested regularly during medication. If elevated transaminases are found, hepatoprotective drugs (such as glycyrrhizic acid preparations, polyene phosphatidylcholine, etc.) may be considered for intervention. If necessary, the dosage of mobotinib may be adjusted or the drug may be temporarily discontinued.

4.Heart monitoring measures

It is recommended to perform an electrocardiogram before using mobotinib and to monitor the QT interval regularly during treatment. If the QT interval is significantly prolonged, consideration should be given to discontinuing the drug or reducing the dose. At the same time, the presence of drug interactions or electrolyte abnormalities should be evaluated and corrected in a timely manner.

5. Comprehensive management suggestions

Patients should establish good living habits while taking the medication, including maintaining adequate sleep, moderate exercise, and a balanced diet. During the initial period of taking the medication, physical reactions should be closely observed, and any discomfort should be reported to the doctor in a timely manner. Family members should also provide appropriate support and help patients record the occurrence time and severity of adverse reactions so that doctors can evaluate and adjust treatment plans.

3. Medication guidance and conclusion

Although adverse reactions to mobotinib are common, most are predictable, controllable, and reversible. The key lies in close communication between the patient and medical team to identify and deal with all types of reactions in a timely manner. Doctors often adjust dosage or combine supportive care based on individual tolerance to minimize side effects while controlling the disease.

In short, as an innovative targeted drug, mobotinib is effective in treating EGFR exons20Insertion mutations have shown significant clinical value in non-small cell lung cancer. For possible side effects, scientific evaluation, early prevention and comprehensive intervention are important guarantees to ensure the smooth progress of treatment. Patients should adhere to standardized medication under the guidance of doctors and maintain a positive attitude towards treatment, so as to achieve a balance between maximum efficacy and minimum adverse effects.

References：https://en.wikipedia.org/wiki/Mobocertinib